Alzheimer’s Disease (AD) is the most prevailing type of dementia. The prevalence of AD is estimated to be around 5% after 65 years old and is staggering 30% for more than 85 years old in developed countries. AD destroys brain cells causing people to lose their memory, mental functions and ability to continue daily activities. The findings of this study are likely to aid specialists in their decision-making process by using patients’ Magnetic Resonance Imaging (MRI) to distinguish patients with AD from Normal Control (NC). Performance evolution was applied to 346 Magnetic Resonance images from the Alzheimer's Neuroimaging Initiative (ADNI) collection. The Deep Belief Network (DBN) classifier was used to fulfill classification function. Weights were used to test the proposed method's recognition capacity, and the network was trained with a sample training set. As a result, this study offeres a new method for identifying Alzheimer's disease utilizing automated categorization. In tests, it performed admirably With 98.46% accuracy achieved for AD and NC studied classes when combining Gray Level Co-occurrence Matrix (GLCM) features with a DBN.
